Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isorhapontigenin, a bioavailable dietary polyphenol, suppresses airway epithelial cell inflammation through a corticosteroid‐independent mechanism
Samuel Chao Ming Yeo, Peter Fenwick, Peter J. Barnes, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 13, pp. 2043-2059
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research
Angelo A. Izzo, Mauro Martins Teixeira, S P H Alexander, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 10, pp. 2169-2178
Open Access | Times Cited: 194
Polyphenols in the treatment of autoimmune diseases
Haroon Khan, Antoni Sureda, Tarun Belwal, et al.
Autoimmunity Reviews (2019) Vol. 18, Iss. 7, pp. 647-657
Open Access | Times Cited: 186
More Than Resveratrol: New Insights into Stilbene-Based Compounds
Paulina Pecyna, Joanna Warguła, Marek Murias, et al.
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1111-1111
Open Access | Times Cited: 117
Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation
Wamidh H. Talib, Izzeddin Alsalahat, Safa Daoud, et al.
Molecules (2020) Vol. 25, Iss. 22, pp. 5319-5319
Open Access | Times Cited: 94
Exploring the role of polyphenols in rheumatoid arthritis
Tapan Behl, Keshav Mehta, Aayush Sehgal, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 19, pp. 5372-5393
Closed Access | Times Cited: 62
Isorhapontigenin Attenuates Cardiac Microvascular Injury in Diabetes via the Inhibition of Mitochondria-Associated Ferroptosis Through PRDX2-MFN2-ACSL4 Pathways
Yuqiong Chen, Li Su, Ming Yin, et al.
Diabetes (2022) Vol. 72, Iss. 3, pp. 389-404
Open Access | Times Cited: 55
Resveratrol and Other Natural Oligomeric Stilbenoid Compounds and Their Therapeutic Applications
Cosmina-Gabriela Duta-Bratu, George Mihai Nițulescu, Dragoș Paul Mihai, et al.
Plants (2023) Vol. 12, Iss. 16, pp. 2935-2935
Open Access | Times Cited: 37
Advances in the activity of resveratrol and its derivatives in cardiovascular diseases
Yaling Peng, Xing Zheng, Si Zhang, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 2
Closed Access | Times Cited: 1
Oral delivery system enhanced the bioavailability of stilbenes: Resveratrol and pterostilbene
Ru‐Min Peng, Guan‐Ru Lin, Yuwen Ting, et al.
BioFactors (2018) Vol. 44, Iss. 1, pp. 5-15
Closed Access | Times Cited: 65
Bioavailability of resveratrol: Possibilities for enhancement
Konrad de Vries, Morné Strydom, Vanessa Steenkamp
Journal of Herbal Medicine (2017) Vol. 11, pp. 71-77
Open Access | Times Cited: 63
Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells
Ning Zhang, Xiaohui Hua, Huailu Tu, et al.
Cancer Letters (2021) Vol. 520, pp. 400-408
Open Access | Times Cited: 42
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD
Yaw‐Syan Fu, Ning Kang, Yanping Yu, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 220028-220028
Open Access | Times Cited: 33
Senotherapy
Jonathan Baker, Louise Donnelly, Peter J. Barnes
CHEST Journal (2020) Vol. 158, Iss. 2, pp. 562-570
Closed Access | Times Cited: 47
Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
Panxia Wang, Minghui Wang, Yuehuai Hu, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 3, pp. 680-693
Open Access | Times Cited: 41
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation
Divyashree Ravishankar, Dina A. I. Albadawi, Vishaant Chaggar, et al.
European Journal of Pharmacology (2019) Vol. 862, pp. 172627-172627
Open Access | Times Cited: 42
Exploration of Nutraceutical Potentials of Isorhapontigenin, Oxyresveratrol and Pterostilbene: A Metabolomic Approach
Yu Dai, Jingbo Wang, Yuhui Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11027-11027
Open Access | Times Cited: 4
Pulmonary Diseases and Ageing
Peter J. Barnes
Sub-cellular biochemistry/Subcellular biochemistry (2019), pp. 45-74
Closed Access | Times Cited: 35
A Stilbenoid Isorhapontigenin as a Potential Anti-Cancer Agent against Breast Cancer through Inhibiting Sphingosine Kinases/Tubulin Stabilization
Lalita Subedi, Mahesh Kumar Teli, Jae Lee, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1947-1947
Open Access | Times Cited: 35
Pre-clinical Pharmacokinetic and Metabolomic Analyses of Isorhapontigenin, a Dietary Resveratrol Derivative
Yu Dai, Samuel Chao Ming Yeo, Peter J. Barnes, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 34
Targeting defective pulmonary innate immunity – A new therapeutic option?
Kylie Belchamber, Louise Donnelly
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107500-107500
Closed Access | Times Cited: 31
Recent advances in chemistry and bioactivity of Sargentodoxa cuneata
Wen Zhang, Cheng‐Peng Sun, Shuang Zhou, et al.
Journal of Ethnopharmacology (2021) Vol. 270, pp. 113840-113840
Closed Access | Times Cited: 27
Isorhapontigenin, a Potential Anti-Ad Natural Product by Multiple Pathways, Discovered Via Network Proximity and Gene Enrichment Analyses
Pengfei Guo, Pengfei Guo, Jun Zhao, et al.
(2025)
Closed Access
Ruthenium-Catalyzed Transfer Hydrogenation of Alkynes: Access to Alkanes and (E)- or (Z)-Alkenes in Tandem with Pd/Cu Sonogashira Cross-Coupling
Dominik Jankovič, Janez Košmrlj, Martin Gazvoda
The Journal of Organic Chemistry (2025)
Open Access
The dual missions of FoxO3a in inflammatory diseases: Regulation of antioxidant enzymes and involvement in programmed cell death
Xiangli Ma, Yujie Lin, Ling Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114369-114369
Closed Access
Page 1 - Next Page

Scroll to top